G Aliberti

1.1k total citations
51 papers, 664 citations indexed

About

G Aliberti is a scholar working on Oncology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G Aliberti has authored 51 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Epidemiology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G Aliberti's work include Radiopharmaceutical Chemistry and Applications (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Thyroid Cancer Diagnosis and Treatment (7 papers). G Aliberti is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Thyroid Cancer Diagnosis and Treatment (7 papers). G Aliberti collaborates with scholars based in Italy, United States and Netherlands. G Aliberti's co-authors include Emilio Bombardieri, Marco Maccauro, Ettore Seregni, Maria Rita Castellani, Elisabetta Romagnoli, G. F. Mazzuoli, E D’Erasmo, Claudio Chiesa, Carlo Villano and Giovanni Lucignani and has published in prestigious journals such as The Lancet, Cancer and Annals of Oncology.

In The Last Decade

G Aliberti

47 papers receiving 642 citations

Peers

G Aliberti
Hae Jin Park South Korea
Metin Kır Türkiye
Myong Kim South Korea
M. Berman United States
Hae Jin Park South Korea
G Aliberti
Citations per year, relative to G Aliberti G Aliberti (= 1×) peers Hae Jin Park

Countries citing papers authored by G Aliberti

Since Specialization
Citations

This map shows the geographic impact of G Aliberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Aliberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Aliberti more than expected).

Fields of papers citing papers by G Aliberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Aliberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Aliberti. The network helps show where G Aliberti may publish in the future.

Co-authorship network of co-authors of G Aliberti

This figure shows the co-authorship network connecting the top 25 collaborators of G Aliberti. A scholar is included among the top collaborators of G Aliberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Aliberti. G Aliberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maccauro, Marco, Matteo Bauckneht, Margarita Kirienko, et al.. (2024). The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE. European Journal of Nuclear Medicine and Molecular Imaging. 52(1). 291–304. 11 indexed citations
3.
Lorenzoni, Alice, Valentina Guadalupi, G Aliberti, et al.. (2021). Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects. Tumori Journal. 108(4). 315–325. 4 indexed citations
4.
Raimondi, Alessandra, Pierangela Sepe, Mélanie Claps, et al.. (2020). Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori. Tumori Journal. 106(5). 406–412. 6 indexed citations
5.
Lorenzoni, Alice, Natalie Prinzi, Sara Pusceddu, et al.. (2020). 1180P Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well differentiated GEPNETs. Annals of Oncology. 31. S780–S780.
6.
Diacinti, Daniele, Daniela Pisani, Francesco Barone‐Adesi, et al.. (2009). A new predictive index for vertebral fractures: The sum of the anterior vertebral body heights. Bone. 46(3). 768–773. 17 indexed citations
7.
Chiesa, Claudio, Maria Rita Castellani, A. Negri, et al.. (2009). Individualized dosimetry in the management of metastatic differentiated thyroid cancer.. PubMed. 53(5). 546–61. 40 indexed citations
8.
Castellani, Maria Rita, Ettore Seregni, Marco Maccauro, et al.. (2008). MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?. PubMed. 52(4). 430–40. 34 indexed citations
9.
Chiesa, Claudio, Francesca Botta, Angela Coliva, et al.. (2007). Dosimetry in Myeloablative 90 Y-Labeled Ibritumomab Tiuxetan Therapy: Possibility of Increasing Administered Activity on the Base of Biological Effective Dose Evaluation. Preliminary Results. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 113–120. 17 indexed citations
10.
Savelli, Giordano, Giovanni Lucignani, Ettore Seregni, et al.. (2004). Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nuclear Medicine Communications. 25(5). 445–449. 29 indexed citations
11.
Maccauro, Marco, Giovanni Lucignani, G Aliberti, et al.. (2004). Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. European Journal of Nuclear Medicine and Molecular Imaging. 32(5). 569–574. 80 indexed citations
12.
Aliberti, G, et al.. (2003). Bone metabolism in ochronotic patients. Journal of Internal Medicine. 254(3). 296–300. 32 indexed citations
13.
Aliberti, G, et al.. (2002). The lungs and platelet production. Clinical & Laboratory Haematology. 24(3). 161–164. 7 indexed citations
14.
Minisola, Salvatore, R. Rosso, Elisabetta Romagnoli, et al.. (2002). Uneven Deficits in Vertebral Bone Density in Postmenopausal Patients with Primary Hyperparathyroidism as Evaluated by Posterior–Anterior and Lateral Dual-Energy Absorptiometry. Osteoporosis International. 13(8). 618–623. 8 indexed citations
15.
Bombardieri, Emilio, et al.. (2001). Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer. Seminars in Surgical Oncology. 20(2). 134–146. 17 indexed citations
16.
Minisola, Salvatore, M. T. Pacitti, R. Rosso, et al.. (1997). The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism. Journal of Endocrinological Investigation. 20(9). 559–565. 9 indexed citations
17.
D’Erasmo, E, et al.. (1991). Hypocalcemia and hypomagnesemia in cancer patients. Biomedicine & Pharmacotherapy. 45(7). 315–317. 12 indexed citations
18.
Aliberti, G, et al.. (1991). Effect of the acute sublingual administration of ketanserin in hypertensive patients. Cardiovascular Drugs and Therapy. 5(4). 697–699. 2 indexed citations
19.
D’Erasmo, E, G Aliberti, Francesco S. Celi, et al.. (1990). Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. Journal of Internal Medicine. 227(1). 11–14. 104 indexed citations
20.
D’Erasmo, E, G Aliberti, E Vecci, Francesco S. Celi, & G. F. Mazzuoli. (1988). Evaluation of platelet changes in completed ischemic stroke. Neurological Sciences. 9(6). 573–576. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026